Mark E. Ewen
- Oncology top 0.2%
- Cancer-related Molecular Pathways 38
- Molecular Biology top 0.5%
- Ubiquitin and proteasome pathways 7
- Retinoids in leukemia and cellular processes 5
- Ophthalmology top 0.5%
- Ocular Oncology and Treatments 8
- Cell Biology top 0.5%
- Microtubule and mitosis dynamics 6
- Cancer Research top 1%
- Cancer, Hypoxia, and Metabolism 5
-
- Virus-based gene therapy research 12
-
- Cancer Research and Treatments 7
- Co-authors
- David M. LivingstonJun‐ya KatoC J SherrJames A. DeCaprioHayla K. SlussHitoshi MatsushimeJeanne B. LawrenceH Matsushime
- Partner nations
- United StatesJapanAustralia
In The Last Decade
Mark E. Ewen
54 papers receiving 10.2k citations
Hit Papers
Peers
Comparison fields: 5 of 117
- Oncology 6.7k
- Molecular Biology 7.1k
- Ophthalmology 812
- Cell Biology 1.4k
- Cancer Research 1.1k
Countries citing papers authored by Mark E. Ewen
This map shows the geographic impact of Mark E. Ewen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mark E. Ewen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mark E. Ewen more than expected).
Fields of papers citing papers by Mark E. Ewen
This network shows the impact of papers produced by Mark E. Ewen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mark E. Ewen. The network helps show where Mark E. Ewen may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mark E. Ewen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 13 | |
| 2 | 2011 | 18 | |
| 3 | 2005 | 38 | |
| 4 | 2004 | 121 | |
| 5 | 2003 | 331 | |
| 6 | 2003 | 26 | |
| 7 | 2003 | 40 | |
| 8 | 2000 | 73 | |
| 9 | 2000 | 90 | |
| 10 | 1998 | 140 | |
| 11 | 1998 | 10 | |
| 12 | 1997 | 315 | |
| 13 | 1996 | 47 | |
| 14 | 1996 | 21 | |
| 15 | 1994 | 251 | |
| 16 | Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4breakdown → | 1993 | 1065 |
| 17 | 1993 | 467 | |
| 18 | Functional interactions of the retinoblastoma protein with mammalian D-type cyclinsbreakdown → | 1993 | 894 |
| 19 | Identification and properties of an atypical catalytic subunit (p34PSK-J3/cdk4) for mammalian D type G1 cyclinsbreakdown → | 1992 | 797 |
| 20 | 1988 | 14 |
About Mark E. Ewen
Mark E. Ewen is a scholar working on Oncology, Ophthalmology, Biotechnology, Genetics and Molecular Biology, having authored 54 papers that have together received 10.4k indexed citations. Recurring topics across this work include Cancer-related Molecular Pathways (38 papers), Virus-based gene therapy research (12 papers), Ocular Oncology and Treatments (8 papers), Ubiquitin and proteasome pathways (7 papers), Cancer Research and Treatments (7 papers), Microtubule and mitosis dynamics (6 papers), Retinoids in leukemia and cellular processes (5 papers) and Cancer, Hypoxia, and Metabolism (5 papers). The work is most often cited by research in Oncology (6.7k citations), Molecular Biology (7.1k citations), Ophthalmology (812 citations), Cell Biology (1.4k citations) and Cancer Research (1.1k citations). Mark E. Ewen has collaborated with scholars based in United States, Japan and Australia. Frequent co-authors include David M. Livingston, Jun‐ya Kato, C J Sherr, James A. DeCaprio, Hayla K. Sluss, Hitoshi Matsushime, Jeanne B. Lawrence, H Matsushime, Scott W. Hiebert and Richard Eckner. Their work appears in journals such as Molecular and Cellular Biology, Cell, Genes & Development, Virology and Cancer Cell.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.